BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26222098)

  • 1. Sterile Corneal Infiltrates Secondary to Psoriasis Exacerbations: Topical Tacrolimus as an Alternative Treatment Option.
    Gonzalez-Andrades M; Arias-Santiago S; García-Serrano JL; González Gallardo MD; McAlinden C
    Eye Contact Lens; 2017 Jan; 43(1):e1-e3. PubMed ID: 26222098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
    Kroft EB; Erceg A; Maimets K; Vissers W; van der Valk PG; van de Kerkhof PC
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):249-51. PubMed ID: 15752305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus ointment is effective for facial and intertriginous psoriasis.
    Lebwohl M; Freeman AK; Chapman MS; Feldman SR; Hartle JE; Henning A;
    J Am Acad Dermatol; 2004 Nov; 51(5):723-30. PubMed ID: 15523350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients.
    Brune A; Miller DW; Lin P; Cotrim-Russi D; Paller AS
    Pediatr Dermatol; 2007; 24(1):76-80. PubMed ID: 17300658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasis.
    Tirado-Sánchez A; Ponce-Olivera RM
    Cutis; 2012 Sep; 90(3):140-4. PubMed ID: 23094314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%.
    Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A
    Drugs Exp Clin Res; 2005; 31(4):141-5. PubMed ID: 16223203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic corneal abscess.
    Moadel K; Perry HD; Donnenfeld ED; Zagelbaum B; Ingraham HJ
    Am J Ophthalmol; 1995 Jun; 119(6):800-1. PubMed ID: 7785699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tacrolimus in high-risk corneal transplants.
    Bernardes L; Gil J; Costa E; Tavares C; Rosa A; Quadrado MJ; Murta J
    Eur J Ophthalmol; 2024 Jan; 34(1):140-145. PubMed ID: 37128645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study.
    De Simone C; Maiorino A; Tassone F; D'Agostino M; Caldarola G
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1003-6. PubMed ID: 22788697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
    Scheinfeld N
    Dermatol Online J; 2004 Jul; 10(1):3. PubMed ID: 15347485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH; Chiu HC; Tseng YS; Tsai TF
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis.
    Rivard J; Janiga J; Lim HW
    J Drugs Dermatol; 2006 Jun; 5(6):505-10. PubMed ID: 16774101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
    Levinger E; Trivizki O; Shachar Y; Levinger S; Verssano D
    Graefes Arch Clin Exp Ophthalmol; 2014 May; 252(5):811-6. PubMed ID: 24696044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of inverse psoriasis with excimer therapy and tacrolimus ointment.
    Carrascosa JM; Soria X; Domingo H; Ferrándiz C
    Dermatol Surg; 2007 Mar; 33(3):361-3. PubMed ID: 17338698
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis.
    Kymionis GD; Kankariya VP; Kontadakis GA
    Cornea; 2012 Aug; 31(8):950-2. PubMed ID: 22525784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with topical tacrolimus for oral psoriasis.
    Yamamoto T; Nishioka K
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1137-8. PubMed ID: 16987275
    [No Abstract]   [Full Text] [Related]  

  • 17. Psoriatic cheilitis: a report of 2 cases treated successfully with topical tacrolimus and a review of the literature.
    Apalla Z; Sotiriou E; Trigoni A; Ioannides D
    Actas Dermosifiliogr; 2015 Oct; 106(8):687-9. PubMed ID: 26164836
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments.
    Brill TJ; Elshorst-Schmidt T; Valesky EM; Kaufmann R; Thaçi D
    Dermatology; 2005; 211(4):351-5. PubMed ID: 16286746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical tacrolimus 0.03% for the treatment of ocular psoriasis.
    Rodríguez-Ausín P; Antolín-Garcia D; Ruano Del Salado M; Hita-Antón C
    Arch Soc Esp Oftalmol; 2016 Oct; 91(10):505-7. PubMed ID: 27130870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques.
    Martín Ezquerra G; Sánchez Regaña M; Herrera Acosta E; Umbert Millet P
    J Drugs Dermatol; 2006 Apr; 5(4):334-6. PubMed ID: 16673800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.